Innoprot, established in 2007 as a spin-off from the University of the Basque Country, is a leading biotechnology company specializing in the provision of cutting-edge products and technologies for multiplexing cell-based assays in drug discovery and development. Our offerings encompass a diverse range of solutions, including primary cells, immortalized cell lines, and recombinant cell lines.